New Delhi: Me gamo tam pa Fresenius Medical Care, dul ma ki lwongo ni Specialty Expert Committee (SEC) me Central Drugs Standard Control Organization (CDSCO) gu miiyo tam bot kampuni ni me cwalo tyen lok me moko tam gi kacel ki ngec ma ki nongo ki i dul me III me calcium chloride dihydrate ki ngec ma ki nongo ki i lobe mukene ma ki moko ni ki moko.
Dul ne con oketo waraga me yubu ki cato calcium chloride dihydrate solution ma tye ki rwom me 100 mmol/L, ma ki tiyo kwede me "cato calcium replacement in continuous renal replacement therapy (CRRT), continuous low-efficiency (daily) dialysis (CLED) ki therapeutic plasma exchange (ETP) with citrate product. ber pi dano madongo ki lutino" ki owaco tyen lok me kwanyo gi ki i dul me adek ki dul me angwen me temo yat.
Dul ni owaco ni jami ni ki yee i lobo Europe calo Portugal, United Kingdom, Brazil, Switzerland, France ki Denmark.
Gin ma ki lwongo ni calcium chloride dihydrate ni CaCl2 2H2O, ma en aye calcium chloride ma tye ki molecule aryo me pii pi unit acel me calcium chloride. En tye gin ma nen calo ryal, ma twero gonyo i pii ki twero mako pii ki i yamo.
Calcium chloride dihydrate obedo gin ma ki tiyo kwede me juku chitin ka ki juku i methanol. Tiimo tic ma pire tek me turo kit ma ki yubu kwede chitin ki tye ki tic mapol i dul ma kwako jami ma ki lwongo ni chemistry.
I cokke pa SEC Nephrology ma obedo i nino dwe 20 me dwe me abic mwaka 2025, dul ni otemo neno tam me yer yubu ki cato 100 mmol/L calcium chloride dihydrate infusion solution me tic kwede i "calcium replacement therapy in continuous renal replacement therapy (CRRT), continuous low-efficiency (DAily) loko remo (TPE) ki citrate anticoagulation. Gin ni ki nyutu i kom dano madongo ki lutino" ki omiyo tyen lok me kwanyo gi ki i dul me III ki IV me temo i ot yat.
Iyonge lok matut, komiti ni omi tam ni gin ma omyera ki yer, kacel ki ngec ma ki nongo ki i dul me adek ki ngec ma ki nongo i nge cato wil ki i lobo ma guye ni yat ni, omyera ki cwalo bot komiti ni me medo ki neno ne.
Kwan bene: CDSCO Group oye ni ki lok manyen i kom Sanofi's Myozyme, ki penyo pi neno cik
Daktal Divya Kolin tye latin kwan ma otum ki kwan me PharmD ki ngec madwong i kom ot yat ki diro me nongo two ki cango two. En bene otiyo calo latic ma miyo yat i dul ma neno lok kom two ma mako remo i Mysore Medical College ki Research Institute. En tye ka lubo tic me kwan ma mako yot kom ki gwoko ngec ma mako yot kom. En obedo ka tic ki Medical Dialogue nicako i dwe me acel mwaka 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Kwano pa ABYSS onongo ni juko tic ki yadi ma gengo two ma mako cuny okelo dongo i rwom me remo, rwom me cwiny, ki peko ma twero bino i kom remo: ...